Literature DB >> 6842019

Serologic study of two clusters of infection due to Campylobacter jejuni.

M J Blaser, D J Duncan, M T Osterholm, G R Istre, W L Wang.   

Abstract

The serologic responses to Campylobacter jejuni in persons involved in two clusters of infection and in control subjects were studied. In the first cluster, in which previously unexposed persons drank raw milk, the attack rate was high and elevated complement-fixing (CF) and specific IgG and IgM antibodies were demonstrated. In the second cluster, involving farmers who chronically drank raw milk, the attack rate was low, but titers of CF and IgG antibodies were high in both affected and unaffected persons. At a control dairy farm, where raw milk was drunk regularly, asymptomatic infection and high CF titers were demonstrated. In contrast to the findings in the first cluster, the titers of IgM antibody among the dairy farmers were low. These studies suggest that chronic exposure to C. jejuni may lead to immunity that may possibly be mediated by IgG.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6842019     DOI: 10.1093/infdis/147.5.820

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  16 in total

1.  Campylobacter: epidemiological paradoxes.

Authors:  J Cowden
Journal:  BMJ       Date:  1992-07-18

2.  Campylobacter jejuni isolations from Mexican and Swedish patients, with repeated symptomatic and/or asymptomatic diarrhoea episodes.

Authors:  E Sjögren; G Ruiz-Palacios; B Kaijser
Journal:  Epidemiol Infect       Date:  1989-02       Impact factor: 2.451

3.  Antibody responses to Campylobacter infections determined by an enzyme-linked immunosorbent assay: 2-year follow-up study of 210 patients.

Authors:  M A Strid; J Engberg; L B Larsen; K Begtrup; K Mølbak; K A Krogfelt
Journal:  Clin Diagn Lab Immunol       Date:  2001-03

4.  Campylobacter jejuni antibodies in Nigerian children.

Authors:  E A Ani; T Takahashi; R A Shonekan
Journal:  J Clin Microbiol       Date:  1988-03       Impact factor: 5.948

5.  Assessment of the duration of protection in Campylobacter jejuni experimental infection in humans.

Authors:  David R Tribble; Shahida Baqar; Daniel A Scott; Michael L Oplinger; Fernando Trespalacios; David Rollins; Richard I Walker; John D Clements; Steven Walz; Paul Gibbs; Edward F Burg; Anthony P Moran; Lisa Applebee; A Louis Bourgeois
Journal:  Infect Immun       Date:  2010-01-19       Impact factor: 3.441

6.  Modulation of mucosal immunity against Campylobacter jejuni by orally administered cytokines.

Authors:  S Baqar; N D Pacheco; F M Rollwagen
Journal:  Antimicrob Agents Chemother       Date:  1993-12       Impact factor: 5.191

7.  Human serum antibody response to Campylobacter jejuni infection as measured in an enzyme-linked immunosorbent assay.

Authors:  M J Blaser; D J Duncan
Journal:  Infect Immun       Date:  1984-05       Impact factor: 3.441

8.  Immune response to and histopathology of Campylobacter jejuni infection in ferrets (Mustela putorius furo).

Authors:  Kevin W Nemelka; Ammon W Brown; Shannon M Wallace; Erika Jones; Ludmila V Asher; Dawn Pattarini; Lisa Applebee; Theron C Gilliland; Patricia Guerry; Shahida Baqar
Journal:  Comp Med       Date:  2009-08       Impact factor: 0.982

9.  Human serum antibody response in Campylobacter jejuni enteritis as measured by enzyme-linked immunosorbent assay.

Authors:  P Herbrink; H A van den Munckhof; M Bumkens; J Lindeman; W C van Dijk
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1988-06       Impact factor: 3.267

10.  Immunogenicity and protective efficacy of recombinant Campylobacter jejuni flagellum-secreted proteins in mice.

Authors:  Shahida Baqar; Lisa A Applebee; Theron C Gilliland; Lanfong H Lee; Chad K Porter; Patricia Guerry
Journal:  Infect Immun       Date:  2008-04-21       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.